Boehringer Ingelheim introduces beta social game Syrum to promote science and innovation
 
Ingelheim, Germany
Tuesday, September 18, 2012, 16:30 Hrs [IST]

Boehringer Ingelheim has launched first beta social game on Facebook, called Syrum outside the US and Canada to actively encourage feedback from the players and will be constantly developed based on the players’ ideas and thoughts. The official global launch of Syrum is planned for 2013.

Syrum will be a new and evolving platform for the research-driven pharmaceutical company to inspire and educate in a changing digital world.

In development for more than two years, Syrum has been specifically designed to demonstrate the complex processes around medicine research and development through gaming mechanics. It aims at promoting science and innovation to the digital community in a fun and engaging way.

"The use of gaming in education has been put to effective use all over the world as more organisations appreciate that humans are better motivated and stimulated by interaction, fun and engagement", says Dr Jez Rose, behavioural psychologist from Buckinghamshire, United Kingdom. "Syrum is a fantastic example of how fun gaming can be used to provide educational delivery, whilst maintaining interest and engagement through a logical, platform learning style."

Syrum allows players to create and run their own pharmaceutical company, using a virtual laboratory to discover and develop imaginary medicines to improve the health of the world. Molecular compounds can be developed and then traded with other players.  In each ‘chapter’, the player has to solve a particular problem, whether a disease or a pandemic.  The goal is to discover cures by first creating a stable medicine, conducting a clinical trial and finally bringing the medicine to the market.

"The research driven pharmaceutical industry is immersed in education - whether aimed at medical or pharmaceutical professionals or providing information directly to the public," says John Pugh, director of Digital at Boehringer Ingelheim. "Gaming is an experimental way for Boehringer Ingelheim to do this. The challenge is to do this in a truly engaging, educational and entertaining way that immerses the player."

Syrum is built on Facebook, and has already generated a high level of interest, both within the pharmaceutical industry and amongst gamers. More than 1,000 people have already signed up to play in advance of the launch via the website www.syrum-game.com.

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies and has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

Source: Pharmabiz.com

 
Other Related News:
TeamLease annual report indicates double digit increments in pharma, healthcare sectors
Karnataka govt to invest Rs.90 cr to set up Arogya Soudha to house all offices of health dept
Commerce Ministry to develop short term strategy to achieve projected pharma export target by 2015
CCEA approves National AIDS Control Support Project at a cost of Rs.2550 crore
US FDA allows marketing of Roche's Tina-quant HbA1cDx assay test for diagnosing diabetes
DPT says many HCs reject demands to have qualified pharmacists to dispense drugs
DBT launches programme to enhance capacity, capability in dengue research
IDMA opposes 45 days time set by DoP for clearing old stocks & enforcing new rates
Otsuka Pharma, Fresenius Kabi Japan ink distribution pact for HES products
New data demonstrate significant & sustained blood pressure reduction with Boston Vessix Renal Denervation System